Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, College of Medicine, Yonsei University, Seoul, South Korea.
Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, College of Medicine, Yonsei University, Seoul, South Korea.
Am J Kidney Dis. 2023 Apr;81(4):384-393.e1. doi: 10.1053/j.ajkd.2022.08.017. Epub 2022 Oct 12.
RATIONALE & OBJECTIVE: The association between short-term blood pressure variability (BPV) and kidney outcomes is poorly understood. This study evaluated the association between short-term BPV and kidney disease outcomes in people with hypertension.
Prospective observational cohort study.
SETTING & PARTICIPANTS: 1,173 hypertensive participants in the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (2013-2018) Study with estimated glomerular filtration rate (eGFR) ≥60mL/min/1.73m.
Short-term BPV assessed by average real variability (ARV).
Composite kidney disease outcome (30% decline in eGFR from baseline, new occurrence of eGFR <60mL/min/1.73m, or onset of UACR >300mg/g).
Multivariable Cox regression analyses to evaluate the association between systolic and diastolic BP ARV (SBP-ARV and DBP-ARV) and outcomes.
During a median follow-up of 5.4 [4.1-6.5] years, 271 events of the composite kidney disease outcome occurred (46.5 per 1,000 person-years). Multivariable Cox analysis revealed that the highest SBP-ARV and DBP-ARV tertiles were associated with a higher risk of the composite kidney disease outcome than the lowest tertiles, independent of the 24-hour SBP or DBP levels (HR, 1.64 [95% CI, 1.16-2.33], and 1.60 [95% CI, 1.15-2.24] for SBP-ARV and DBP-ARV, respectively). These associations were consistent when SBP-ARV and DBP-ARV were treated as continuous variables (HR per 1.0-unit greater SBP-ARV, 1.03 [95% CI, 1.01-1.06]; HR per 1.0-unit greater DBP-ARV, 1.04 [95% CI, 1.01-1.08]). These associations were consistent, irrespective of subgroups (age, sex, 24-hour SBP or DBP, and moderate albuminuria). However, other measures of short-term BPV including SD, coefficient of variation, and dipping patterns were not associated with the composite kidney disease outcome.
Observational study design, the use of single measurement of 24-hour BP, lack of information on changes in antihypertensive medication during the follow-up.
Short-term BPV is associated with the development of a composite kidney disease outcome in hypertensive patients.
短期血压变异性(BPV)与肾脏结局之间的关系尚未完全阐明。本研究旨在评估高血压患者短期 BPV 与肾脏疾病结局之间的关系。
前瞻性观察性队列研究。
心血管和代谢疾病病因学研究中心-高危人群(2013-2018 年)研究中 1173 名估计肾小球滤过率(eGFR)≥60mL/min/1.73m 的高血压参与者。
通过平均真实变异性(ARV)评估短期 BPV。
复合肾脏疾病结局(eGFR 自基线下降 30%,eGFR<60mL/min/1.73m 新发生或 UACR>300mg/g)。
多变量 Cox 回归分析评估收缩压和舒张压 ARV(SBP-ARV 和 DBP-ARV)与结局之间的关系。
在中位随访 5.4[4.1-6.5]年期间,发生了 271 例复合肾脏疾病结局事件(46.5 例/1000 人年)。多变量 Cox 分析显示,与最低三分位相比,SBP-ARV 和 DBP-ARV 的最高三分位与复合肾脏疾病结局的风险增加相关,而与 24 小时 SBP 或 DBP 水平无关(HR,1.64[95%CI,1.16-2.33]和 1.60[95%CI,1.15-2.24],分别用于 SBP-ARV 和 DBP-ARV)。当 SBP-ARV 和 DBP-ARV 作为连续变量处理时,这些关联仍然一致(每增加 1.0 单位 SBP-ARV,HR 为 1.03[95%CI,1.01-1.06];每增加 1.0 单位 DBP-ARV,HR 为 1.04[95%CI,1.01-1.08])。这些关联在亚组(年龄、性别、24 小时 SBP 或 DBP 和中度白蛋白尿)中是一致的。然而,其他短期 BPV 测量指标,包括 SD、变异系数和降压模式与复合肾脏疾病结局无关。
观察性研究设计、24 小时 BP 的单次测量、随访期间降压药物变化信息的缺乏。
短期 BPV 与高血压患者复合肾脏疾病结局的发生有关。